RecruitingPhase 3NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Fontana, CA · La Jolla, CA · La Palma, CA · +28 more sites